123
Participants
Start Date
February 29, 2012
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
D9421-C capsule 3 mg
Patients randomised to D9421-C 9 mg will take 3 capsules of D9421-C capsule 3 mg once daily before breakfast and 4 tablets of Mesalazine tablets placebo three times a day after each meal for 8 weeks.
Mesalazine tablets
Patients randomised to Mesalazine 3 g will take 3 capsules of D9421-C capsule placebo once daily before breakfast and 4 tablets of Mesalazine tablets 250 mg three times a day after each meal for 8 weeks.
Research Site, Chikushino-shi
Research Site, Fukuoka
Research Site, Fukuyama-shi
Research Site, Hirosaki-shi
Research Site, Hiroshima
Research Site, Kagoshima
Research Site, Kitakyushu-shi
Research Site, Koshigaya-shi
Research Site, Kurume-shi
Research Site, Kyoto
Research Site, Nagakute-shi
Research Site, Nagoya
Research Site, Nishinomiya-shi
Research Site, Okayama
Research Site, Omura-shi
Research Site, Osaka
Research Site, Ōita
Research Site, Sakura
Research Site, Sapporo
Research Site, Sendai
Research Site, Shinjyuku-ku
Research Site, Suginami-ku
Research Site, Suita-shi
Research Site, Toyoake-shi
Research Site, Toyota-shi
Lead Sponsor
AstraZeneca
INDUSTRY